PET Physics & PET/CT
- PET maps a radiotracer that emits positrons — the antimatter twin of the electron. When a positron meets an electron, both vanish and turn into two photons.
- Those two photons fly off in opposite directions (180° apart). PET listens for both at once — a "coincidence" — and draws a line through the body that the decay happened somewhere along.
- The workhorse tracer is FDG, a glucose look-alike. Hungry cells (tumors, infection, brain, heart) gobble it up and light up.
- PET tells you where activity is but is blurry on anatomy. CT tells you exactly where things are. PET/CT fuses them so the bright spot lands on a real structure.
- The CT also does double duty: it provides the attenuation correction map that fixes PET's brightness for the tissue the photons had to punch through.
Most imaging shoves energy into you — X-rays, sound, magnetic fields — and watches what bounces back. PET does the opposite. We inject a tiny amount of radioactive sugar, then sit back and wait for you to glow. It's the one scan where the patient is the light bulb.
Antimatter, in a hospital gown
Here's the part that sounds made up but is completely real. PET tracers are made with isotopes that decay by spitting out a positron — an electron with a positive charge, genuine antimatter. The positron doesn't get far. It zips a millimeter or two through tissue, bumps into an ordinary electron, and the two annihilate: matter plus antimatter, both gone, converted entirely into energy.
That energy leaves as two photons of 511 keV each, and — because momentum has to balance — they shoot off in almost exactly opposite directions, 180° apart. Think of it like a tiny, perfectly fair pool break where the cue ball and the eight ball are guaranteed to roll to opposite ends of the table.
That little hop the positron takes before annihilating ("positron range") is one reason PET can never be pin-sharp — by the time the photons are made, the signal has already wandered a hair away from where the tracer actually sat.
Coincidence detection: catching both ends of the line
A ring of detectors surrounds the patient. When two 511 keV photons strike the ring at essentially the same instant on opposite sides, the scanner says, "those are twins from one annihilation," and records a coincidence. Draw a straight line between those two detectors — the line of response — and you know the decay happened somewhere along it.
Collect millions of these lines from millions of decays, let them crisscross, and the bright crossing points reconstruct into an image. No physical lead collimator is doing the aiming here — the back-to-back photon geometry is the collimation. That's a key difference from the single-photon world of the gamma camera and SPECT, which has to use heavy collimators and throws away most of its photons to figure out direction.
FDG: a glucose decoy
The tracer you'll meet over and over is FDG (fluorine-18 fluorodeoxyglucose) — glucose with a radioactive fluorine swapped in. Cells that are metabolically greedy haul it inside just like real sugar. But FDG is a decoy: once phosphorylated, it can't be fully broken down, so it gets trapped inside the cell and accumulates. Busy cells therefore stack up signal over time.
What's "busy"? Many tumors, sites of infection and active inflammation, and — entirely normally — the brain, the heart, and the urinary tract (FDG is cleared in the urine, so the kidneys and bladder light up like a lighthouse). This is the source of the most useful PET concept and its biggest trap at the same time.
"Bright" does not equal "cancer." Infection, inflammation, brown fat, recently exercised muscle, and normal brain/heart/bladder all show high FDG uptake. PET shows metabolism, not malignancy — you read it in context, never in isolation.
Why bolt a CT onto it
A PET image alone is a fuzzy cloud of activity floating in space. Gorgeous, but try telling a surgeon "it's the bright blob, roughly... there." That's why modern scanners are PET/CT: the patient slides through a CT and a PET in one session, and the two datasets are fused. The CT supplies crisp anatomy; the PET drops its glow precisely onto the right node, nodule, or bone.
The CT pulls a second shift, too. Photons born deep in the body get partly attenuated — absorbed and scattered — before they ever reach the ring, so a deep liver lesion looks dimmer than an identical one near the skin purely because of the tissue in the way. The CT is essentially a map of how dense each voxel is, and the scanner uses it to perform CT-based attenuation correction, mathematically restoring each region's true brightness. (If the idea of denser tissue eating more of the beam is new, detour through attenuation and radiographic contrast.)
Attenuation correction is also a classic artifact factory. If the patient breathes or shifts so the CT and PET don't line up, or if dense metal or contrast skews the CT map, the corrected PET can show false uptake or shove a hot spot off its real location. When something looks weird, always peek at the uncorrected images.
Reading the brightness: SUV
To avoid eyeballing "kinda bright," PET gives a semi-quantitative number, the standardized uptake value (SUV) — roughly, how concentrated the tracer is in a spot compared with an even spread across the whole body. Higher SUV means more avid uptake. It's genuinely handy for tracking a tumor across scans, but treat it as a trend, not gospel: SUV drifts with the time since injection, blood sugar, body size, and scanner settings, so comparing across machines is shaky.
If you remember one thing: PET shows function, CT shows form, and PET/CT lets a metabolic glow land on a real anatomic address — which is exactly what makes it so good at hunting cancer and infection that a plain CT would stroll right past.